KYNB·31572Q881·US·equity·Healthcare - Biotechnology-13D/G
KYNB (KYNTRA BIO INC) is held by 18 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($571,765), TWO SIGMA INVESTMENTS, LP ($335,685), GEODE CAPITAL MANAGEMENT, LLC ($311,935). Net institutional sentiment: Bearish.
See how KYNB's score breaks down across 4 SEC sources
Showing 1-20 of 25
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer